Research Conference Poster Index
Plan your conference by viewing the poster presentation sessions at this year's Research Conference
| P1 | Development of an immunoassay based device for measuring cortisol as a marker of stress in patients with neurodegenerative conditions Katherine Deane, University of East Anglia |
|---|---|
| P4 | Investigating the biomarker potential of post-translationally modified α-synuclein in cerebral spinal fluid Craig Leighton, University of Edinburgh |
| P7 | Monitoring Parkinson's using smartphones and behavioural inferences Julio Vega, University of Manchester |
| P10 | Moving to the music, not the beat: embodied sensorimotor entrainment in Parkinson's Dawn Rose, University of Hertfordshire |
| P13 | Multimorbidity predicts quality of life but not motor severity in early Parkinson's Rachael Lawson, Institute of Neuroscience, Newcastle University |
| P16 | Pierre D – the story behind one of the most prominent images in Parkinson's Patrick Lewis, University of Reading |
| P19 | Newcastle-upon-Tyne deep brain stimulation rehabilitation project Heather Hunter, Newcastle-upon-Tyne Hospitals NHS Foundation Trust |
| P22 | Developing a multi-arm, multi-stage (MAMS) trial platform in Parkinson's Thea Dominey, Plymouth University Peninsula Schools of Medicine and Dentistry |
| P25 |
Evidence for altered top-down processing of pain in Parkinson's |
| P28 | Difficulty desynchronising beta activity underlies memory deficits in Parkinson's Hayley MacDonald, University of Birmingham |
| P31 | The Parkinson's linked protein DJ-1 associates with cytoplasmic mRNP granules during stress and neurodegeneration Mariaelena Repici, University of Leicester |
| P34 | Changes in muscle activity on application of an auditory rhythmic cue Aisha Islam, Newcastle University |
| P37 | Study of α-synuclein aggregates toxicity with a nanopipette delivery system Chalmers Chi Cheng Chau, University of Leeds |
| P40 | AKT signalling selectively regulates PINK1 mitophagy in SHSY5Y cells and human iPSC-derived neurons Marc Soutar, UCL |
| P43 | Single cell transcriptomic dynamics of human dopamine neurons Hugo Fernandes, Dementia Research Institute, Cambridge |
| P46 | Exploring the pathogenic role of dRab39 in a Drosophila model of Parkinson's Charlotte Smith, University of Leicester |
| P49 | Down-regulation of MMP2 and TGFB1 in Parkinson's LRRK2 G2019S iPSC-derived astrocytes Frank Wessely, Dementia Research Institute, Cardiff University |
| P52 | A model system for uptake and aggregation of pre-formed fibrillar α-synuclein in iPSC-derived dopamine neurons Siv Vingill, University of Oxford |
| P55 | Tonic GABA inhibition of striatal dopamine transmission is regulated by GABA transporter activity and augmented in parkinsonian mice Bradley Roberts, University of Oxford |
| P58 | Strategies to regenerate the nigrostriatal pathway in an organotypic rat model of Parkinson's Timothy Goodman, Keele University |
| P61 | Mass-spectrometry approach highlights REST as a potential neuroprotective target for Parkinson's in an alpha synuclein overexpressing BAC-transgenic mouse model Nora Bengoa-Vergniory, OPDC |
| P64 | Regulation of basal mitophagy and pexophagy by the mitochondrial deubiquitylase USP30 Jane Jardine, University of Liverpool |
| P67 | Human-specific levels of CDNF, MANF and ER stress in the pathological progression of Parkinson's Ilaria Poggiolini, Nuffield Department of Clinical Neuroscience, Oxford Parkinson’s Disease Centre |
| P70 | Development of a home-based therapy to improve functional actions in people with Parkinson's using observation and imagery Ellen Poliakoff, University of Manchester |
| P73 | Exploring the roles of vitamins in the differentiation and protection of dopamine neurons Emma Green, Keele University |
| P76 | How patient and public involvement shaped the development of a training tool for impulse control disorders in Parkinson's Jade Pickering, University of Manchester |
| P79 | How do people with Parkinson's respond to expression and meaning in dance? Judith Bek, University of Manchester |
| P82 | The effect of aerobic exercise on cognition in people with Parkinson's: a modified systematic review Grace Chillingworth, RJAH Orthopaedic Hospital NHS FT, Oswestry |
| P85 | Manual to automated process transfer of pluripotent cell expansion and differentiation for the production of dopaminergic neurons as a cell therapy for Parkinson's Preeti Holland, Loughborough University |
| P88 | Wrist-worn accelerometer measures of activity by people with Parkinson's during and in the week following participation in a dance class Rebecca Hadley, University of Hertfordshire |
| P5 | Automated measures from neuromelanin-sensitive MRI reveal signs of neurodegeneration in rapid eye movement sleep behaviour disorder Ludovica Griffanti, University of Oxford |
|---|---|
| P8 | Co-creation of guidance and quality criteria for patient engagement in the development of clinical interventions: an international multi-stakeholder initiative Katherine Deane, University of East Anglia (on behalf of the Patient Focused Medicines Development Coalition) |
| P11 | Pro-saccades predict cognitive decline in Parkinson's Rachael Lawson, Newcastle University |
| P14 | Frailty status predicts falls in early Parkinson's Alison Yarnall, Institute of Neuroscience, Newcastle University |
| P17 | Smartphone prediction of clinical motor scores and future falls, freezing and disability in the Oxford Discovery cohort Christine Lo, University of Oxford |
| P20 | A multi-centre randomised controlled trial to compare the linical and cost effectiveness of Lee Silverman voice treatment versus standard NHS speech and language therapy versus control in Parkinson’s (PD COMM) Max Hughes, University of Birmingham |
| P23 | Structural neural correlates of independent gait characteristics in Parkinson’s Joanna Wilson, Institute of Neuroscience, Newcastle University |
| P26 |
Interaction of LRRK2 with Rab GTPases in vivo |
| P29 | p27Kip1regulates alpha-synuclein expression Edurne Gallastegui, University of Barcelona, Barcelona, Spain |
| P32 | Anxiety in Parkinson's: the role of the locus coeruleus-stress circuitry Mohsen Seifi, University of Portsmouth |
| P35 | Integrated systems approach to identify genetic networks and hubs in Parkinson's Jack Kelly, University of Plymouth |
| P38 | Mitochondrial deficiencies in LRRK2-G2019S Parkinson's Ruby Macdonald, Sheffield Institute for Translational Neuroscience, University of Sheffield |
| P41 | Endosomal trafficking dysfunction in Parkinson's Kirsty McMillan, University of Bristol |
| P44 | Transcriptomic analysis of induced pluripotent stem cell derived dopaminergic neurons from patients with sporadic Parkinson's Jimena Monzón Sandoval, Cardiff University |
| P47 | Investigating low-level single nucleotide mosaicism in sporadic Parkinson's Melissa Leija-Salazar, University College London |
| P50 | Early Synaptic changes in the CRISPR-engineered G51D αSynuclein rat Stephen West, Centre for Regenerative Medicine, University of Edinburgh |
| P53 | Engineering synucleinopathy-resistant human dopaminergic neurons by CRISPR-mediated deletion of the SNCA gene Yixi Chen, MRC Centre for Regenerative Medicine, University of Edinburgh |
| P56 | Mitochondrial abnormalities in parkin mutant patient derived dopaminergic neurons are driven by the metabolic status of the neuron Aurelie Schwartzentruber, Sheffield Institute for Translational Neuroscience |
| P59 | Dopamine pre and post-synaptic signalling in a LRRK2 transgenic rodent model of Parkinson's using 18F-Levodpa and 18F-Fallypride PET imaging Teresa Delgado-Goni, Oxford Parkinson's Disease Centre |
| P62 | Alterations in mitochondrial function and network in iAstrocytes derived from parkin mutant patients Heather Mortiboys, University of Sheffield |
| P65 | Three-dimensional and stereological characterisation of the Human Pedunculopontine nucleus during Parkinson's Ilse Pienaar, University of Sussex |
| P68 | Alginate hydrogels to encapsulate hiPSC-derived neurons for Parkinson's Rachael Evans, Department of Pharmacology, UCL School of Pharmacy |
| P71 | A novel role for SENP3 in iron chelation-induced mitophagy for the treatment of Parkinson's Emily Waters, University of Sheffield |
| P74 | Do gabapentinoid drugs have neuroprotective or therapeutic potential for the treatment of Parkinson's? Katherine Brimblecombe, University of Oxford |
| P77 | Assessing the effect of small molecule glucocerebrosidase modulators on GBA-associated phenotypes in iPSC-derived dopaminergic neuronal cultures Uroosa Chughtai, Oxford Parkinson's Disease Centre |
| P80 | A co-developed dance programme for Parkinson's: pilot testing and potential outcomes Aline Arakaki, University of Manchester |
| P83 | Human action influences hand movements more than simple cues in Parkinson's Judith Bek, University of Manchester |
| P86 | Suppression of Caspases and NFκB classical pathway enhanced survival of stressed dopaminergic neurons Bushra Ahmed, University of Bedfordshire |
| P89 | Translational requirements for manufactured dopaminergic neurons for the treatment of Parkinson's James Kusena, Centre for Biological Engineering, Loughborough University |
| P3 | Reduced habit-driven errors in Parkinson's Colin Bannard, University of Liverpool |
|---|---|
| P6 | Patient experiences of receiving a diagnosis of Parkinson's S Modi, Department of Clinical Neurosciences, UCL Institute of Neurology |
| P9 | Use of iPad-based pre-assessment questionnaires in Parkinson's clinics: a qualitative study of patients' perceptions Amani Khardali, School of Pharmacy and Pharmaceutical Sciences, Cardiff University |
| P12 | The Evidence Based Practice Committee and the UK Parkinson’s Excellence Network Alison Yarnall, Institute of Neuroscience, Newcastle University |
| P15 | Is dual task walking associated with cognitive impairment in Parkinson's? Laura Stuart, Institute of Neuroscience |
| P18 | Show me the way: gesturing about space in Parkinson's Ellen Poliakoff, University of Manchester |
| P21 | Top 10 research priorities for the management of Parkinson's. An international cross-sectional survey in the frame of the CENTRE-PD project Francesca Bowring, Oxford University/UCL |
| P24 | Prefrontal cortical activity decreases in people with Parkinson's when performing a cognitively challenging walking task compared to usual walking Annette Pantall, Newcastle University |
| P27 |
Human-specific transcriptomic profiling of ventral and dorsal midbrain dopamine neurons |
| P30 | Cell signalling in live brains, neurones and immune cells in LRRK2 Parkinson's disease models Kirsten Harvey, University College London |
| P33 | Exploiting cellular heterogeneity through single cell sequencing reveals HDAC4 as a regulator of cellular phenotypes in Parkinson's dopamine neurons Charmaine Lang, University of Oxford |
| P36 | A quantitative proteomics assessment of the substantia nigra revealed dysregulation of glial proteins in aged rats: implications for idiopathic Parkinson's Yolanda Gómez-Gálvez, Institute for Science and Technology in Medicine (Keele University) |
| P39 | Apathy in rapid eye movement sleep behaviour disorder is associated with serotonin depletion in the dorsal raphe nucleus Thomas Barber, University of Oxford |
| P42 | High content screening to identify modulators of mitophagy in neurodegenerative disease Daniela Melandri, University College London |
| P45 | Somatic copy number gains of the alpha-synuclein gene in synucleinopathies Christos Proukakis, UCL Institute of Neurology |
| P48 | Prioritisation of GWAS genes in Parkinson's associated loci through interaction networks identifies dopaminergic-specific genes showing functional and genetic convergence in independent datasets Viola Volpato, Cardiff University |
| P51 | Linking Leucine rich repeat kinase 2 (LRRK2) – Parkinson's and inflammation Rina Bandopadhyay, Reta Lila Weston Institute, UCL Institute of Neurology |
| P54 | Depicting mitochondrial function and mitophagy in Parkinson's patient iPSC-derived dopaminergic neurons Marta Cherubini, Oxford Parkinson’s Disease Centre and Department of Physiology, University of Oxford |
| P57 | Insights into the role of LRRK2 in the endocytic pathway and identification of novel LRRK2 substrates Natalie Connor-Robson, University of Oxford |
| P60 | Does dysregulation of calcium homeostasis converge with maturing neurotransmission to cause long-term energy deficit in GBA iPSC derived neurons? Dayne Beccano-Kelly, University of Oxford |
| P63 | Astrocytes in Parkinson's Lucy Crompton, University of Bristol |
| P66 | The observed association between dementia with Lewy bodies, APOE-ɛ4 and TOMM40 Poly-T repeat long allele variants is due to co-existing Alzheimer's pathology Clara Erixon, Department of Medical and Health Sciences, Linkoping University, Linkoping, Sweden |
| P69 | The effectiveness of peroneal nerve functional electrical STimulation (FES) for the reduction of bradykinesia in Parkinson's: a pragmatic feasibility study for an assessor-blinded randomised control trial (STEPS) Paul Taylor, Salisbury NHS Foundation Trust |
| P72 | Non-invasive vagus nerve stimulation: a non-pharmacological approach to target gait impairment in Parkinson's? Alison Yarnall, Institute of Neuroscience, Newcastle University |
| P75 | Tools to monitor the production of a midbrain dopaminergic precursor cell product Nicola Drummond, The University of Edinburgh |
| P78 | A targeted repurposing approach to find Food and Drug Administration (FDA) approved drugs that boost endogenous fibroblast growth factor 20 for use in future neuroprotective studies Edward Fletcher, King's College London |
| P81 | Phenotypic drug discovery in iPSC-derived dopaminergic neuronal cultures Janine Brandes, University of Oxford |
| P84 | Screening of novel modified steroids for mitochondrial rescue effect in Parkinson's Christopher Hastings, University of Sheffield |
| P87 | Mitochondrial high content image screening in Parkinson's patient tissue Heather Mortiboys, University of Sheffield |
| P90 | Identifying novel drugs and targets through integrating phenotypic screening data across Parkinson's models Brent Ryan, OPDC, University of Oxford |
Latest information
All announcements on the conference will be made via our e-newsletter Synapse.
For any questions please contact:
- [email protected]
- 0207 963 9315